MONTELUKAST SODIUM
NDC 16571-100, MONTELUKAST SODIUM, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-100
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MONTELUKAST SODIUM10 mg/1
Pharmacologic classes
Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-100-09 | 16571010009 | 90 TABLET in 1 BOTTLE (16571-100-09) |
| 16571-100-10 | 16571010010 | 1000 TABLET in 1 BOTTLE (16571-100-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/75723c5a-3c9e-468a-bc65-57b4c755889aNADAC price for package 16571010009
GET /v1/drugs/nadac/16571010009NADAC price for package 16571010010
GET /v1/drugs/nadac/16571010010
Use it
Look up 16571-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.